Biodel Inc. BIOD +27% - Reported positive preliminary results from Phase 2a clinical trial of BIOD-531.
BIND Therapeutics BIND +22% - Provided clinical update for BIND-014.
NephroGenex Inc. NRX +15% - The company received positive advice from the European Medicines Agency Regarding its Phase 3 program with Pyridorin.
Mistras Group Inc. MG +12% - Shares are moving higher following financial results.
Resources Connection Inc. RECN +6% - Shares are higher following the company’s upbeat second quarter results.
Ultragenyx Pharmaceuticals RARE +4.8%- Announced license of IP related to treatment for Huntington’s disease.
Insulet Corporation PODD -8% - Lowered FY2014 Sales guidance from $292-297M to $287-289M vs $296M estimate.
WD-40 Company WDFC -4.6% - The company reported first quarter results.
Alexion Pharmaceuticals ALXN -4.4% - Provided update on Phase 2 clinical trial with Eculizumab.
AmTrust Financial Services Inc. AFSI - 3.7% - Announced a 3 million share offering.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
